Jorge DiMartino's most recent trade in Kronos Bio Inc was a trade of 12,009 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Jan. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 04 Jan 2024 | 12,009 | 315,246 | - | 1.2 | 14,214 | Common Stock |
Kronos Bio Inc | DiMartino Jorge | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 12 Dec 2023 | 17,367 | 327,255 | - | 1.3 | 22,664 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 06 Jul 2023 | 10,818 | 344,622 | - | 1.8 | 18,956 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 24 Feb 2023 | 10,153 | 355,440 | - | 1.7 | 17,621 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 205,513 | 205,513 | - | - | Employee Stock Option (Right to Buy) | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 137,008 | 365,593 | - | 0 | Common Stock | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 12 Dec 2022 | 18,657 | 219,478 | - | 1.8 | 33,680 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 60,300 | 238,135 | - | 0 | Common Stock | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 60,300 | 177,835 | - | 0 | Common Stock | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 13 Dec 2021 | 16,152 | 117,785 | - | 12.4 | 199,687 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 13 Dec 2021 | 250 | 117,535 | - | 12.8 | 3,206 | Common Stock |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 200,906 | 200,906 | - | - | Employee Stock Option (Right to Buy) | |
Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 133,937 | 133,937 | - | 0 | Common Stock |